Canagliflozin for the treatment of adults with Type 2 diabetes
| dc.contributor.author | Aschner Montoya, Pablo | |
| dc.date.accessioned | 2021-03-01T20:26:15Z | |
| dc.date.accessioned | 2023-05-11T19:43:13Z | |
| dc.date.available | 2021-03-01T20:26:15Z | |
| dc.date.available | 2023-05-11T19:43:13Z | |
| dc.date.created | 2013 | |
| dc.identifier | https://www.openaccessjournals.com/abstract/canagliflozin-for-the-treatment-of-adults-with-type-2-diabetes-8095.html | spa |
| dc.identifier.issn | 1758-1907 | spa |
| dc.identifier.uri | https://hdl.handle.net/20.500.12032/118517 | |
| dc.format | spa | |
| dc.format.mimetype | application/pdf | spa |
| dc.language.iso | eng | spa |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | * |
| dc.title | Canagliflozin for the treatment of adults with Type 2 diabetes | spa |
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
| canagliflozin-f ... s-with-type-2-diabetes.pdf | 640.0Kb | application/pdf | View/ |
This item appears in the following Collection(s)
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc/4.0/